Results 161 to 170 of about 151,016 (323)
Malaria Research and Treatment, 2019 Background Malaria is a protozoan disease caused by the Plasmodium species. Among the five Plasmodium species. Among the five Plasmodium falciparum and Plasmodium vivax malaria are by far the most predominant and widely distributed in Ethiopia.
Teshiwal Deress, M. Girma
semanticscholar +1 more source
Imported Plasmodium vivax Malaria in the Russian Federation from Western Sub-Saharan Africa
Journal of Tropical Medicine, 2019 Background. Imported cases of Plasmodium vivax malaria from western Africa are reported annually in the Russian Federation. Infected native African people moving from western Africa for different purposes (students, businessmen, specialists, etc.) or ...
Alla Baranova +4 more
doaj +1 more source
Malaria Journal, 2009 Background The SD FK80 P.f/P.v Malaria Antigen Rapid Test (Standard Diagnostics, Korea) (FK80) is a three-band malaria rapid diagnostic test detecting Plasmodium falciparum histidine-rich protein-2 (HRP-2) and Plasmodium vivax-specific lactate ...
Van Esbroeck Marjan +5 more
doaj +1 more source
Evaluation of Three Rapid Tests for Diagnosis of P. Falciparum and P. Vivax Malaria in Colombia. [PDF]
, 2006 The diagnostic capacity of three malaria rapid diagnostic tests (RDTs), NOW-Malaria-ICT, OptiMAL-IT, and Paracheck-Pf, was evaluated against expert microscopy in Colombia. We tested 896 patients, of whom microscopy confirmed 139 P.
Angarita, B +6 more
core +1 more source
Primate malarias: Diversity, distribution and insights for zoonotic Plasmodium [PDF]
, 2015 Protozoans within the genus Plasmodium are well-known as the causative agents of malaria in humans. Numerous Plasmodium species parasites also infect a wide range of non-human primate hosts in tropical and sub-tropical regions worldwide.
Dobson, Andrew P., Faust, Christina
core +2 more sources
Altered Gut Microbiota and Immunity Defines Plasmodium vivax Survival in Anopheles stephensi
bioRxiv, 2019 Blood feeding-enriched gut-microbiota boosts mosquitoes’ anti-Plasmodium immunity. Here, we ask how Plasmodium vivax alters microbiota, anti-Plasmodial immunity and impact tripartite Plasmodium-mosquito-microbiota interactions in the gut lumen.
Punita Sharma +7 more
semanticscholar +1 more source
Development of vaccines for Plasmodium vivax malaria
Vaccine, 2015 Plasmodium vivax continues to cause significant morbidity outside Africa with more than 50% of malaria cases in many parts of South and South-east Asia, Pacific islands, Central and South America being attributed to P. vivax infections. The unique biology of P. vivax, including its ability to form latent hypnozoites that emerge months to years later to
Ahmad Rushdi Shakri +3 more
openaire +4 more sources
Review of pyronaridine anti-malarial properties and product characteristics. [PDF]
, 2012 Pyronaridine was synthesized in 1970 at the Institute of Chinese Parasitic Disease and has been used in China for over 30 years for the treatment of malaria.
Arbe-Barnes, Sarah J +7 more
core +2 more sources
Plasmodium vivax chloroquine resistance links to pvcrt transcription in a genetic cross
Nature Communications, 2019 Mainstay treatment for Plasmodium vivax malaria has long relied on chloroquine (CQ) against blood-stage parasites plus primaquine against dormant liver-stage forms (hypnozoites), however drug resistance confronts this regimen and threatens malaria ...
Juliana M. Sá +37 more
semanticscholar +1 more source
An unusual case of heart failure due to Plasmodium vivax infection with a favorable outcome
Revista da Sociedade Brasileira de Medicina Tropical, 2014 Although malaria is one of the oldest types of parasitic infection, we have recently witnessed substantial changes in the outcome of malarial infections.
Nishanth Dev +3 more
doaj +1 more source